GlassScriptPhysician profile
Claudio Alejandro Palma
NPI 1154348464
$2,652.01
in general payments reported to CMS, 2019-2025
21 companies · $931 in 2025
The $931 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $678 · 2020: $356 · 2021: $355 · 2022: $160 · 2023: $76.12 · 2024: $94.69 · 2025: $931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $625.73 | 2019-2025 | Xtampza, Belbuca |
| Indivior INC. | $272.79 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $226.22 | 2019-2025 | Relistor |
| Pfizer INC. | $192.10 | 2019-2025 | |
| Curonix LLC | $187.86 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $159.67 | 2019-2025 | Proclaim, Eterna |
| Abbvie INC. | $149.35 | 2025 | |
| Nevro Corp. | $118.19 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $112.57 | 2019-2021 | |
| Boston Scientific Corporation | $100.39 | 2019-2022 | |
| Hikma Pharmaceuticals USA | $75.51 | 2021-2022 | |
| Trevena, INC. | $73.78 | 2021 | |
| Merz Pharmaceuticals, LLC | $66.74 | 2025 | Xeomin |
| Orexo US, INC. | $54.50 | 2019 | |
| Scilex Pharmaceuticals INC. | $49.24 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $46.50 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $40.35 | 2024-2025 | |
| Si-Bone, INC. | $39.49 | 2019 | |
| Convatec INC. | $26.86 | 2025 | Aquacel Ag Surgical |
| Ferring Pharmaceuticals INC. | $23.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudio Palma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.